Loading…

Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells

Neprilysin (NEP) is a plasma membrane-bound peptidase with wide expression in kidney, lung, brain and bone. Decreased NEP activity has been linked to increased growth of some cancer cells, but it is unknown whether its activity is related to growth of cells belonging to the osteoblast lineage. We as...

Full description

Saved in:
Bibliographic Details
Published in:Regulatory peptides 2005-08, Vol.130 (1), p.57-66
Main Authors: Schmid, Christoph, Ghirlanda-Keller, Claudia, Gosteli-Peter, Martina
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c390t-e382923121b26bb8ee5d751556fe3f74f70c94db8a508a88abea62b8a3f2a50c3
cites cdi_FETCH-LOGICAL-c390t-e382923121b26bb8ee5d751556fe3f74f70c94db8a508a88abea62b8a3f2a50c3
container_end_page 66
container_issue 1
container_start_page 57
container_title Regulatory peptides
container_volume 130
creator Schmid, Christoph
Ghirlanda-Keller, Claudia
Gosteli-Peter, Martina
description Neprilysin (NEP) is a plasma membrane-bound peptidase with wide expression in kidney, lung, brain and bone. Decreased NEP activity has been linked to increased growth of some cancer cells, but it is unknown whether its activity is related to growth of cells belonging to the osteoblast lineage. We assessed NEP activity in an osteoblastic cell line, PyMS, by cleavage of N-Dansyl- d-Ala-Gly- p-nitro-Phe-Gly to Dansyl- d-Ala-Gly. NEP activity was completely blocked by 1 μM thiorphan. Most agents affecting growth of these cells (e.g. calcium, insulin-like growth factor I and dexamethasone) did not regulate NEP activity. Ascorbic acid (ASA) increased thymidine incorporation into DNA and potentiated the stimulatory effect of IGF I on DNA synthesis, an effect which was attenuated by echistatin. ASA decreased NEP activity in a dose-dependent manner, and decreased Western-detectable NEP protein in plasma membranes. ASA affects both integrin receptor-mediated signalling and the processing of regulatory peptides.
doi_str_mv 10.1016/j.regpep.2005.03.007
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68024840</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167011505001163</els_id><sourcerecordid>68024840</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-e382923121b26bb8ee5d751556fe3f74f70c94db8a508a88abea62b8a3f2a50c3</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVpaTZp_0EpvrQ3uyPL-vClEJY0CQRyac5ClsZFi9feauRA_n207EJuOQ0annln9DD2jUPDgatfuybhvwMemhZANiAaAP2BbbjRoubKqI9sUzBdA-fygl0S7QC41Fp8Zhdc9mCgFRv2dE1-SUP0lfMxVAF9QkdI1YxrTm6qcA5L2ZJjKO0C5fgc80sV58qvU14ThmqhjMswOcolxuM00Rf2aXQT4ddzvWJPf27-bu_qh8fb--31Q-1FD7lGYdq-FbzlQ6uGwSDKoCWXUo0oRt2NGnzfhcE4CcYZ4wZ0qi1PMbal5cUV-3nKPaTl_4qU7T7S8QI347KSVeWTnemggN0J9GkhSjjaQ4p7l14sB3vUaXf2pNMedVoQtugsY9_P-euwx_A2dPZXgB9nwJF305jc7CO9capXnTamcL9PHBYbzxGTJR9x9hhiQp9tWOL7l7wCAyuWcg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68024840</pqid></control><display><type>article</type><title>Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells</title><source>Elsevier</source><creator>Schmid, Christoph ; Ghirlanda-Keller, Claudia ; Gosteli-Peter, Martina</creator><creatorcontrib>Schmid, Christoph ; Ghirlanda-Keller, Claudia ; Gosteli-Peter, Martina</creatorcontrib><description>Neprilysin (NEP) is a plasma membrane-bound peptidase with wide expression in kidney, lung, brain and bone. Decreased NEP activity has been linked to increased growth of some cancer cells, but it is unknown whether its activity is related to growth of cells belonging to the osteoblast lineage. We assessed NEP activity in an osteoblastic cell line, PyMS, by cleavage of N-Dansyl- d-Ala-Gly- p-nitro-Phe-Gly to Dansyl- d-Ala-Gly. NEP activity was completely blocked by 1 μM thiorphan. Most agents affecting growth of these cells (e.g. calcium, insulin-like growth factor I and dexamethasone) did not regulate NEP activity. Ascorbic acid (ASA) increased thymidine incorporation into DNA and potentiated the stimulatory effect of IGF I on DNA synthesis, an effect which was attenuated by echistatin. ASA decreased NEP activity in a dose-dependent manner, and decreased Western-detectable NEP protein in plasma membranes. ASA affects both integrin receptor-mediated signalling and the processing of regulatory peptides.</description><identifier>ISSN: 0167-0115</identifier><identifier>EISSN: 1873-1686</identifier><identifier>DOI: 10.1016/j.regpep.2005.03.007</identifier><identifier>PMID: 15908023</identifier><identifier>CODEN: REPPDY</identifier><language>eng</language><publisher>Shannon: Elsevier B.V</publisher><subject>Alkaline Phosphatase - metabolism ; Animals ; Ascorbic acid ; Ascorbic Acid - metabolism ; Ascorbic Acid - pharmacology ; Biological and medical sciences ; Blotting, Northern ; Blotting, Western ; Calcium - metabolism ; Cell Membrane - metabolism ; Cell Proliferation ; Cells, Cultured - cytology ; Dexamethasone - pharmacology ; DNA - metabolism ; Dose-Response Relationship, Drug ; Fundamental and applied biological sciences. Psychology ; Growth ; Insulin-Like Growth Factor I - pharmacology ; NEP ; Neprilysin - chemistry ; Neprilysin - pharmacology ; Osteoblasts ; Osteoblasts - cytology ; Osteoblasts - metabolism ; Peptides - chemistry ; Rats ; Signal Transduction ; Subcellular Fractions ; Thiorphan - pharmacology ; Thymidine - chemistry ; Thymidine - metabolism ; Time Factors ; Transcriptional Activation ; Vertebrates: endocrinology</subject><ispartof>Regulatory peptides, 2005-08, Vol.130 (1), p.57-66</ispartof><rights>2005 Elsevier B.V.</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-e382923121b26bb8ee5d751556fe3f74f70c94db8a508a88abea62b8a3f2a50c3</citedby><cites>FETCH-LOGICAL-c390t-e382923121b26bb8ee5d751556fe3f74f70c94db8a508a88abea62b8a3f2a50c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16964788$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15908023$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schmid, Christoph</creatorcontrib><creatorcontrib>Ghirlanda-Keller, Claudia</creatorcontrib><creatorcontrib>Gosteli-Peter, Martina</creatorcontrib><title>Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells</title><title>Regulatory peptides</title><addtitle>Regul Pept</addtitle><description>Neprilysin (NEP) is a plasma membrane-bound peptidase with wide expression in kidney, lung, brain and bone. Decreased NEP activity has been linked to increased growth of some cancer cells, but it is unknown whether its activity is related to growth of cells belonging to the osteoblast lineage. We assessed NEP activity in an osteoblastic cell line, PyMS, by cleavage of N-Dansyl- d-Ala-Gly- p-nitro-Phe-Gly to Dansyl- d-Ala-Gly. NEP activity was completely blocked by 1 μM thiorphan. Most agents affecting growth of these cells (e.g. calcium, insulin-like growth factor I and dexamethasone) did not regulate NEP activity. Ascorbic acid (ASA) increased thymidine incorporation into DNA and potentiated the stimulatory effect of IGF I on DNA synthesis, an effect which was attenuated by echistatin. ASA decreased NEP activity in a dose-dependent manner, and decreased Western-detectable NEP protein in plasma membranes. ASA affects both integrin receptor-mediated signalling and the processing of regulatory peptides.</description><subject>Alkaline Phosphatase - metabolism</subject><subject>Animals</subject><subject>Ascorbic acid</subject><subject>Ascorbic Acid - metabolism</subject><subject>Ascorbic Acid - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Blotting, Northern</subject><subject>Blotting, Western</subject><subject>Calcium - metabolism</subject><subject>Cell Membrane - metabolism</subject><subject>Cell Proliferation</subject><subject>Cells, Cultured - cytology</subject><subject>Dexamethasone - pharmacology</subject><subject>DNA - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Growth</subject><subject>Insulin-Like Growth Factor I - pharmacology</subject><subject>NEP</subject><subject>Neprilysin - chemistry</subject><subject>Neprilysin - pharmacology</subject><subject>Osteoblasts</subject><subject>Osteoblasts - cytology</subject><subject>Osteoblasts - metabolism</subject><subject>Peptides - chemistry</subject><subject>Rats</subject><subject>Signal Transduction</subject><subject>Subcellular Fractions</subject><subject>Thiorphan - pharmacology</subject><subject>Thymidine - chemistry</subject><subject>Thymidine - metabolism</subject><subject>Time Factors</subject><subject>Transcriptional Activation</subject><subject>Vertebrates: endocrinology</subject><issn>0167-0115</issn><issn>1873-1686</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9kE1r3DAQhkVpaTZp_0EpvrQ3uyPL-vClEJY0CQRyac5ClsZFi9feauRA_n207EJuOQ0annln9DD2jUPDgatfuybhvwMemhZANiAaAP2BbbjRoubKqI9sUzBdA-fygl0S7QC41Fp8Zhdc9mCgFRv2dE1-SUP0lfMxVAF9QkdI1YxrTm6qcA5L2ZJjKO0C5fgc80sV58qvU14ThmqhjMswOcolxuM00Rf2aXQT4ddzvWJPf27-bu_qh8fb--31Q-1FD7lGYdq-FbzlQ6uGwSDKoCWXUo0oRt2NGnzfhcE4CcYZ4wZ0qi1PMbal5cUV-3nKPaTl_4qU7T7S8QI347KSVeWTnemggN0J9GkhSjjaQ4p7l14sB3vUaXf2pNMedVoQtugsY9_P-euwx_A2dPZXgB9nwJF305jc7CO9capXnTamcL9PHBYbzxGTJR9x9hhiQp9tWOL7l7wCAyuWcg</recordid><startdate>20050815</startdate><enddate>20050815</enddate><creator>Schmid, Christoph</creator><creator>Ghirlanda-Keller, Claudia</creator><creator>Gosteli-Peter, Martina</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050815</creationdate><title>Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells</title><author>Schmid, Christoph ; Ghirlanda-Keller, Claudia ; Gosteli-Peter, Martina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-e382923121b26bb8ee5d751556fe3f74f70c94db8a508a88abea62b8a3f2a50c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Alkaline Phosphatase - metabolism</topic><topic>Animals</topic><topic>Ascorbic acid</topic><topic>Ascorbic Acid - metabolism</topic><topic>Ascorbic Acid - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Blotting, Northern</topic><topic>Blotting, Western</topic><topic>Calcium - metabolism</topic><topic>Cell Membrane - metabolism</topic><topic>Cell Proliferation</topic><topic>Cells, Cultured - cytology</topic><topic>Dexamethasone - pharmacology</topic><topic>DNA - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Growth</topic><topic>Insulin-Like Growth Factor I - pharmacology</topic><topic>NEP</topic><topic>Neprilysin - chemistry</topic><topic>Neprilysin - pharmacology</topic><topic>Osteoblasts</topic><topic>Osteoblasts - cytology</topic><topic>Osteoblasts - metabolism</topic><topic>Peptides - chemistry</topic><topic>Rats</topic><topic>Signal Transduction</topic><topic>Subcellular Fractions</topic><topic>Thiorphan - pharmacology</topic><topic>Thymidine - chemistry</topic><topic>Thymidine - metabolism</topic><topic>Time Factors</topic><topic>Transcriptional Activation</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schmid, Christoph</creatorcontrib><creatorcontrib>Ghirlanda-Keller, Claudia</creatorcontrib><creatorcontrib>Gosteli-Peter, Martina</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Regulatory peptides</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schmid, Christoph</au><au>Ghirlanda-Keller, Claudia</au><au>Gosteli-Peter, Martina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells</atitle><jtitle>Regulatory peptides</jtitle><addtitle>Regul Pept</addtitle><date>2005-08-15</date><risdate>2005</risdate><volume>130</volume><issue>1</issue><spage>57</spage><epage>66</epage><pages>57-66</pages><issn>0167-0115</issn><eissn>1873-1686</eissn><coden>REPPDY</coden><abstract>Neprilysin (NEP) is a plasma membrane-bound peptidase with wide expression in kidney, lung, brain and bone. Decreased NEP activity has been linked to increased growth of some cancer cells, but it is unknown whether its activity is related to growth of cells belonging to the osteoblast lineage. We assessed NEP activity in an osteoblastic cell line, PyMS, by cleavage of N-Dansyl- d-Ala-Gly- p-nitro-Phe-Gly to Dansyl- d-Ala-Gly. NEP activity was completely blocked by 1 μM thiorphan. Most agents affecting growth of these cells (e.g. calcium, insulin-like growth factor I and dexamethasone) did not regulate NEP activity. Ascorbic acid (ASA) increased thymidine incorporation into DNA and potentiated the stimulatory effect of IGF I on DNA synthesis, an effect which was attenuated by echistatin. ASA decreased NEP activity in a dose-dependent manner, and decreased Western-detectable NEP protein in plasma membranes. ASA affects both integrin receptor-mediated signalling and the processing of regulatory peptides.</abstract><cop>Shannon</cop><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>15908023</pmid><doi>10.1016/j.regpep.2005.03.007</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0167-0115
ispartof Regulatory peptides, 2005-08, Vol.130 (1), p.57-66
issn 0167-0115
1873-1686
language eng
recordid cdi_proquest_miscellaneous_68024840
source Elsevier
subjects Alkaline Phosphatase - metabolism
Animals
Ascorbic acid
Ascorbic Acid - metabolism
Ascorbic Acid - pharmacology
Biological and medical sciences
Blotting, Northern
Blotting, Western
Calcium - metabolism
Cell Membrane - metabolism
Cell Proliferation
Cells, Cultured - cytology
Dexamethasone - pharmacology
DNA - metabolism
Dose-Response Relationship, Drug
Fundamental and applied biological sciences. Psychology
Growth
Insulin-Like Growth Factor I - pharmacology
NEP
Neprilysin - chemistry
Neprilysin - pharmacology
Osteoblasts
Osteoblasts - cytology
Osteoblasts - metabolism
Peptides - chemistry
Rats
Signal Transduction
Subcellular Fractions
Thiorphan - pharmacology
Thymidine - chemistry
Thymidine - metabolism
Time Factors
Transcriptional Activation
Vertebrates: endocrinology
title Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T21%3A49%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ascorbic%20acid%20decreases%20neutral%20endopeptidase%20activity%20in%20cultured%20osteoblastic%20cells&rft.jtitle=Regulatory%20peptides&rft.au=Schmid,%20Christoph&rft.date=2005-08-15&rft.volume=130&rft.issue=1&rft.spage=57&rft.epage=66&rft.pages=57-66&rft.issn=0167-0115&rft.eissn=1873-1686&rft.coden=REPPDY&rft_id=info:doi/10.1016/j.regpep.2005.03.007&rft_dat=%3Cproquest_cross%3E68024840%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c390t-e382923121b26bb8ee5d751556fe3f74f70c94db8a508a88abea62b8a3f2a50c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68024840&rft_id=info:pmid/15908023&rfr_iscdi=true